Literature DB >> 24033344

Malfolded protein structure and proteostasis in lung diseases.

William E Balch1, Jacob I Sznajder, Scott Budinger, Daniel Finley, Aaron D Laposky, Ana Maria Cuervo, Ivor J Benjamin, Esther Barreiro, Richard I Morimoto, Lisa Postow, Allan M Weissman, Dorothy Gail, Susan Banks-Schlegel, Thomas Croxton, Weiniu Gan.   

Abstract

Recent discoveries indicate that disorders of protein folding and degradation play a particularly important role in the development of lung diseases and their associated complications. The overarching purpose of the National Heart, Lung, and Blood Institute workshop on "Malformed Protein Structure and Proteostasis in Lung Diseases" was to identify mechanistic and clinical research opportunities indicated by these recent discoveries in proteostasis science that will advance our molecular understanding of lung pathobiology and facilitate the development of new diagnostic and therapeutic strategies for the prevention and treatment of lung disease. The workshop's discussion focused on identifying gaps in scientific knowledge with respect to proteostasis and lung disease, discussing new research advances and opportunities in protein folding science, and highlighting novel technologies with potential therapeutic applications for diagnosis and treatment.

Entities:  

Mesh:

Year:  2014        PMID: 24033344      PMCID: PMC3919126          DOI: 10.1164/rccm.201306-1164WS

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  64 in total

Review 1.  Neurobiology and neuropathophysiology of obstructive sleep apnea.

Authors:  Yanpeng Li; Sigrid C Veasey
Journal:  Neuromolecular Med       Date:  2011-12-15       Impact factor: 3.843

Review 2.  Proteostasis strategies for restoring alpha1-antitrypsin deficiency.

Authors:  Marion Bouchecareilh; Juliana J Conkright; William E Balch
Journal:  Proc Am Thorac Soc       Date:  2010-11

Review 3.  In and out of the ER: protein folding, quality control, degradation, and related human diseases.

Authors:  Daniel N Hebert; Maurizio Molinari
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

Review 4.  Endoplasmic reticulum stress and type 2 diabetes.

Authors:  Sung Hoon Back; Randal J Kaufman
Journal:  Annu Rev Biochem       Date:  2012-03-23       Impact factor: 23.643

5.  Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency.

Authors:  Marion Bouchecareilh; Darren M Hutt; Patricia Szajner; Terence R Flotte; William E Balch
Journal:  J Biol Chem       Date:  2012-09-20       Impact factor: 5.157

Review 6.  The alveolar-epithelial barrier: a target for potential therapy.

Authors:  G R Scott Budinger; Jacob I Sznajder
Journal:  Clin Chest Med       Date:  2006-12       Impact factor: 2.878

7.  Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF.

Authors:  W E Lawson; S W Grant; V Ambrosini; K E Womble; E P Dawson; K B Lane; C Markin; E Renzoni; P Lympany; A Q Thomas; J Roldan; T A Scott; T S Blackwell; J A Phillips; J E Loyd; R M du Bois
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

Review 8.  alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies.

Authors:  Ugo I Ekeowa; Bibek Gooptu; Didier Belorgey; Peter Hägglöf; Susanna Karlsson-Li; Elena Miranda; Juan Pérez; Ian MacLeod; Heike Kroger; Stefan J Marciniak; Damian C Crowther; David A Lomas
Journal:  Clin Sci (Lond)       Date:  2009-05-14       Impact factor: 6.124

Review 9.  Recognition and processing of ubiquitin-protein conjugates by the proteasome.

Authors:  Daniel Finley
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

10.  Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants.

Authors:  Wenqing Fu; Timothy D O'Connor; Goo Jun; Hyun Min Kang; Goncalo Abecasis; Suzanne M Leal; Stacey Gabriel; Mark J Rieder; David Altshuler; Jay Shendure; Deborah A Nickerson; Michael J Bamshad; Joshua M Akey
Journal:  Nature       Date:  2012-11-28       Impact factor: 49.962

View more
  23 in total

Review 1.  Aging and Lung Disease. Clinical Impact and Cellular and Molecular Pathways.

Authors:  Mauricio Rojas; Ana L Mora; Maria Kapetanaki; Nathaniel Weathington; Mark Gladwin; Oliver Eickelberg
Journal:  Ann Am Thorac Soc       Date:  2015-12

2.  Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014.

Authors:  Alvar Agustí; Josep Maria Antó; Charles Auffray; Ferran Barbé; Esther Barreiro; Jordi Dorca; Joan Escarrabill; Rosa Faner; Laura I Furlong; Judith Garcia-Aymerich; Joaquim Gea; Bertil Lindmark; Eduard Monsó; Vicente Plaza; Milo A Puhan; Josep Roca; Juan Ruiz-Manzano; Laura Sampietro-Colom; Ferran Sanz; Luis Serrano; James Sharpe; Oriol Sibila; Edwin K Silverman; Peter J Sterk; Jacob I Sznajder
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

3.  Muscle dysfunction in patients with lung diseases: a growing epidemic.

Authors:  Esther Barreiro; Jacob I Sznajder; Gustavo A Nader; G R Scott Budinger
Journal:  Am J Respir Crit Care Med       Date:  2015-03-15       Impact factor: 21.405

Review 4.  Contributions of alveolar epithelial cell quality control to pulmonary fibrosis.

Authors:  Jeremy Katzen; Michael F Beers
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

5.  Stretching to Understand How Proteostasis and the Unfolded Protein Response Regulate Lung Injury.

Authors:  Emilia Lecuona; Jacob I Sznajder
Journal:  Am J Respir Cell Mol Biol       Date:  2017-08       Impact factor: 6.914

Review 6.  The Intersection of Aging Biology and the Pathobiology of Lung Diseases: A Joint NHLBI/NIA Workshop.

Authors:  G R Scott Budinger; Ronald A Kohanski; Weiniu Gan; Michael S Kobor; Luis A Amaral; Mary Armanios; Karl T Kelsey; Annie Pardo; Rubin Tuder; Fernando Macian; Navdeep Chandel; Douglas Vaughan; Mauricio Rojas; Ana L Mora; Elizabeth Kovacs; Steven R Duncan; Toren Finkel; Augustine Choi; Oliver Eickelberg; Danica Chen; Alvar Agusti; Moises Selman; William E Balch; Paula Busse; Anning Lin; Richard Morimoto; Jacob I Sznajder; Victor J Thannickal
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-10-12       Impact factor: 6.053

7.  Accumulation of Ubiquitin and Sequestosome-1 Implicate Protein Damage in Diacetyl-Induced Cytotoxicity.

Authors:  Ann F Hubbs; Kara L Fluharty; Rebekah J Edwards; Jamie L Barnabei; John T Grantham; Scott M Palmer; Francine Kelly; Linda M Sargent; Steven H Reynolds; Robert R Mercer; Madhusudan P Goravanahally; Michael L Kashon; John C Honaker; Mark C Jackson; Amy M Cumpston; William T Goldsmith; Walter McKinney; Jeffrey S Fedan; Lori A Battelli; Tiffany Munro; Winnie Bucklew-Moyers; Kimberly McKinstry; Diane Schwegler-Berry; Sherri Friend; Alycia K Knepp; Samantha L Smith; Krishnan Sriram
Journal:  Am J Pathol       Date:  2016-11       Impact factor: 4.307

8.  SCFFBXO17 E3 ligase modulates inflammation by regulating proteasomal degradation of glycogen synthase kinase-3β in lung epithelia.

Authors:  Tomeka Suber; Jianxin Wei; Anastasia M Jacko; Ina Nikolli; Yutong Zhao; Jing Zhao; Rama K Mallampalli
Journal:  J Biol Chem       Date:  2017-03-15       Impact factor: 5.157

Review 9.  Lost after translation: insights from pulmonary surfactant for understanding the role of alveolar epithelial dysfunction and cellular quality control in fibrotic lung disease.

Authors:  Surafel Mulugeta; Shin-Ichi Nureki; Michael F Beers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-17       Impact factor: 5.464

Review 10.  Blue journal conference. Aging and susceptibility to lung disease.

Authors:  Victor J Thannickal; Mahadev Murthy; William E Balch; Navdeep S Chandel; Silke Meiners; Oliver Eickelberg; Moisés Selman; Annie Pardo; Eric S White; Bruce D Levy; Paula J Busse; Rubin M Tuder; Veena B Antony; Jacob I Sznajder; G R Scott Budinger
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.